Skip to content

Metabolic

Adipotide

Also called FTPP, Prohibitin-targeting peptide

InjectableEvidence CEvery day
Half-life
2hours
Typical vial
5 / 10mg
Research amounts
0.5–1mg

per administration

Common schedule
Every day
Animal or lab only

Only animal or lab studies exist — no human study has set an amount.

Work out your draw

These numbers are a starting point — change any of them.

3 mL cartridge · 300 units loaded30units dialled
Concentration
1.67mg/mL
Volume per draw
0.3mL
Units to dial
30
Doses per cartridge
10

Vial label

Copy this into your label printer.

Published research contexts for Adipotide describe 0.51 mg per administration. Descriptive only, not a recommendation.

Human pharmacokinetics are not published; the figure is an order-of-magnitude estimate.

A prohibitin-targeting pro-apoptotic peptide that reduced fat mass in obese primates; its human phase 1 study was never published. No human dose-ranging data exists and circulating amounts are preclinical or community-derived, so no schedule table is shown.

Modelled level — every day

1× is the peak after a single dose.

Steady-state peak
1.00× single dose

Read off the modelled curve, not an even-interval formula

Time to steady state
10hours

About five half-lives

Administrations
7/ week

Where these numbers come from

  • Barnhart KF et al., Sci Transl Med 2011;3:108ra112Adipotide reduced body weight and adiposity in obese rhesus monkeys; a preclinical primate study, not a human trial.

Next steps